<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Fertil Steril</journal-id><journal-id journal-id-type="iso-abbrev">Int J Fertil Steril</journal-id><journal-id journal-id-type="publisher-id">Royan Institute</journal-id><journal-title-group><journal-title>International Journal of Fertility &amp; Sterility</journal-title></journal-title-group><issn pub-type="ppub">2008-076X</issn><issn pub-type="epub">2008-0778</issn><publisher><publisher-name>Royan Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24520472</article-id><article-id pub-id-type="pmc">3850342</article-id><article-id pub-id-type="other">Int-J-Fertil-Steril-7-108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject><subj-group><subject>Embryology</subject><subject>Art</subject></subj-group></subj-group></article-categories><title-group><article-title>The Effects of ISM1 Medium on Embryo Quality
and Outcomes of IVF/ICSI Cycles</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hassani</surname><given-names>Fatemeh</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eftekhari-Yazdi</surname><given-names>Poopak</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Karimian</surname><given-names>Leila</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rezazadeh Valojerdi</surname><given-names>Mojtaba</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Movaghar</surname><given-names>Bahar</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fazel</surname><given-names>Mohammad</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fouladi</surname><given-names>Hamid Reza</given-names></name><degrees>B.Sc.</degrees><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shabani</surname><given-names>Fatemeh</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Johansson</surname><given-names>Lars</given-names></name><degrees>Ph.D.</degrees><xref ref-type="aff" rid="A3">3</xref><xref ref-type="corresp" rid="cor2">*</xref></contrib><aff id="A1"><label>1</label>Department of Embryology at Reproductive Biomedicine Research Center, Royan Institute for Reproductive
Biomedicine, ACECR, Tehran, Iran</aff><aff id="A2"><label>2</label>Department of Epidemiology and Reproductive Health at Reproductive Epidemiology Research Center, Royan
Institute for Reproductive Biomedicine, ACECR, Tehran, Iran</aff><aff id="A3"><label>3</label>Codra Centre for Assisted Reproduction, Podgorica, Montenegro</aff></contrib-group><author-notes><corresp id="cor1">
* Corresponding Addresses:
<addr-line>P.O.Box: 16635-148</addr-line><addr-line>Department of
Embryology at Reproductive Biomedicine Research Center</addr-line><addr-line>Royan
Institute for Reproductive Biomedicine</addr-line><institution>ACECR</institution><addr-line>Tehran</addr-line><country>Iran</country>
Email: <email>eftekhari@royaninstitute.org</email></corresp><corresp id="cor2"><institution>Codra Centre for Assisted Reproduction</institution><addr-line>Podgorica</addr-line><country>Montenegro</country>
Email: <email>newlifeaid@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2013</year></pub-date><pub-date pub-type="epub"><day>31</day><month>7</month><year>2013</year></pub-date><volume>7</volume><issue>2</issue><fpage>108</fpage><lpage>115</lpage><history><date date-type="received"><day>8</day><month>4</month><year>2012</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="5016" xml_f="5027" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="5038" xml_f="5159" txt_i="23" txt_f="144">The aim of this study is to investigate the effect of ISM1 culture medium
on embryo development, quality and outcomes of </offsets><italic><offsets xml_i="5167" xml_f="5175" txt_i="144" txt_f="152">in vitro</offsets></italic><offsets xml_i="5184" xml_f="5492" txt_i="152" txt_f="460"> fertilization/intracytoplasmic
sperm injection (IVF/ICSI) cycles. This study compares culture medium commonly used
in the laboratory setting for oocyte recovery and embryo development with a medium
from MediCult. We have assessed the effects of these media on embryo development and
newborn characteristics.</offsets></p></sec><sec><title><offsets xml_i="5514" xml_f="5536" txt_i="462" txt_f="484">Materials and Methods:</offsets></title><p><offsets xml_i="5547" xml_f="6087" txt_i="485" txt_f="1025">In this prospective randomized study, fertilized oocytes
from patients were randomly assigned to culture in ISM1 (MediCult, cycles:
n=293) or routine lab culture medium (G-1TM v5; Vitrolife, cycles: n=290) according
to the daily media schedule for oocyte retrieval. IVF or ICSI and embryo
transfer were performed with either MediCult media or routine lab media. Embryo
quality on days 2/3, cleavage, pregnancy and implantation rates, baby take home
rate (BTHR), in addition to the weight and length of newborns were compared
between groups.</offsets></p></sec><sec><title><offsets xml_i="6109" xml_f="6117" txt_i="1027" txt_f="1035">Results:</offsets></title><p><offsets xml_i="6128" xml_f="6522" txt_i="1036" txt_f="1424">There were similar cleavage rates for ISM1 (86%) vs. G-1TM v5 (88%). We
observed a significantly higher percentage of excellent embryos in ISM1 (42.7%) compared
to G-1TM v5 (39%, p&lt;0.05). Babies born after culture in ISM1 had both higher
birth weight (3.03 kg) and length (48.8 cm) compared to G-1TM v5 babies that had a birth
weight of 2.66 kg and a length of 46.0 cm (p&lt;0.001 for both).</offsets></p></sec><sec><title><offsets xml_i="6544" xml_f="6555" txt_i="1426" txt_f="1437">Conclusion:</offsets></title><p><offsets xml_i="6566" xml_f="6734" txt_i="1438" txt_f="1606">This study suggests that ISM1 is a more effective culture medium in
generating higher quality embryos, which may be reflected in the characteristics of
babies at birth.</offsets></p></sec></abstract><kwd-group><kwd>Culture Media</kwd><kwd>Embryo</kwd><kwd>Quality</kwd><kwd>Birth Weight</kwd><kwd>Babiesâ€™ lengths</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>Citation</meta-name><meta-value>Hassani F, Eftekhari-Yazdi P, Karimian L, Rezazadeh Valojerdi M, Movaghar B, Fazel M, Fouladi HR,
Shabani F, Johansson L. The effects of ISM1 medium on embryo quality and outcomes of IVF/ICSI cycles. Int J Fertil
Steril. 2013; 7(2): 108-115</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title><offsets xml_i="7289" xml_f="7301" txt_i="1615" txt_f="1627">Introduction</offsets></title><p><offsets xml_i="7312" xml_f="7477" txt_i="1628" txt_f="1793">The outcome of an assisted reproduction treatment
(ART) cycle is highly dependent on numerous
factors including the clinic location, equipment
and disposables used (</offsets><xref rid="B1" ref-type="bibr"><offsets xml_i="7508" xml_f="7509" txt_i="1793" txt_f="1794">1</offsets></xref><offsets xml_i="7516" xml_f="7532" txt_i="1794" txt_f="1810">), patient age (</offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="7563" xml_f="7564" txt_i="1810" txt_f="1811">2</offsets></xref><offsets xml_i="7571" xml_f="7573" txt_i="1811" txt_f="1813">, </offsets><xref rid="B3" ref-type="bibr"><offsets xml_i="7604" xml_f="7605" txt_i="1813" txt_f="1814">3</offsets></xref><offsets xml_i="7612" xml_f="7637" txt_i="1814" txt_f="1839">), stimulation
regimens (</offsets><xref rid="B4" ref-type="bibr"><offsets xml_i="7668" xml_f="7669" txt_i="1839" txt_f="1840">4</offsets></xref><offsets xml_i="7676" xml_f="7696" txt_i="1840" txt_f="1860">), sperm selection (</offsets><xref rid="B5" ref-type="bibr"><offsets xml_i="7727" xml_f="7728" txt_i="1860" txt_f="1861">5</offsets></xref><offsets xml_i="7735" xml_f="7762" txt_i="1861" txt_f="1888">), culture
condition (pH) (</offsets><xref rid="B6" ref-type="bibr"><offsets xml_i="7793" xml_f="7794" txt_i="1888" txt_f="1889">6</offsets></xref><offsets xml_i="7801" xml_f="7805" txt_i="1889" txt_f="1893">), O</offsets><sub><offsets xml_i="7810" xml_f="7811" txt_i="1893" txt_f="1894">2</offsets></sub><offsets xml_i="7817" xml_f="7819" txt_i="1894" txt_f="1896"> (</offsets><xref rid="B7" ref-type="bibr"><offsets xml_i="7850" xml_f="7851" txt_i="1896" txt_f="1897">7</offsets></xref><offsets xml_i="7858" xml_f="7880" txt_i="1897" txt_f="1919">), and group culture (</offsets><xref rid="B8" ref-type="bibr"><offsets xml_i="7911" xml_f="7912" txt_i="1919" txt_f="1920">8</offsets></xref><offsets xml_i="7919" xml_f="8178" txt_i="1920" txt_f="2179">).
It is recommended that the clinic select a suitable culture system that repeatedly produces high quality
embryos for embryo transfer and cryo-preservation
with low miscarriage rates that results in the
delivery of a healthy baby of normal gestational
age (</offsets><xref rid="B9" ref-type="bibr"><offsets xml_i="8209" xml_f="8210" txt_i="2179" txt_f="2180">9</offsets></xref><offsets xml_i="8217" xml_f="8219" txt_i="2180" txt_f="2182">, </offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="8251" xml_f="8253" txt_i="2182" txt_f="2184">10</offsets></xref><offsets xml_i="8260" xml_f="8262" txt_i="2184" txt_f="2186">).</offsets></p><p><italic><offsets xml_i="8277" xml_f="8285" txt_i="2187" txt_f="2195">In vitro</offsets></italic><offsets xml_i="8294" xml_f="8450" txt_i="2195" txt_f="2351"> culture and development of human embryos
for days 2 or 3 transfers is performed in a
variety of different culture media that range from
simple to complex (</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="8482" xml_f="8484" txt_i="2351" txt_f="2353">11</offsets></xref><offsets xml_i="8491" xml_f="8492" txt_i="2353" txt_f="2354">-</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="8524" xml_f="8526" txt_i="2354" txt_f="2356">13</offsets></xref><offsets xml_i="8533" xml_f="8701" txt_i="2356" txt_f="2524">). Increased knowledge
in the specific requirements for the development of
healthy human pre-implantation embryos has resulted
in the formulation of new culture media (</offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="8732" xml_f="8733" txt_i="2524" txt_f="2525">2</offsets></xref><offsets xml_i="8740" xml_f="8742" txt_i="2525" txt_f="2527">,
</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="8774" xml_f="8776" txt_i="2527" txt_f="2529">14</offsets></xref><offsets xml_i="8783" xml_f="8785" txt_i="2529" txt_f="2531">, </offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="8817" xml_f="8819" txt_i="2531" txt_f="2533">15</offsets></xref><offsets xml_i="8826" xml_f="8928" txt_i="2533" txt_f="2635">) that supports the development of embryos
from fertilization to the fully expanded blastocyst
stage (</offsets><xref rid="B2" ref-type="bibr"><offsets xml_i="8959" xml_f="8960" txt_i="2635" txt_f="2636">2</offsets></xref><offsets xml_i="8967" xml_f="8969" txt_i="2636" txt_f="2638">, </offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="9001" xml_f="9003" txt_i="2638" txt_f="2640">16</offsets></xref><offsets xml_i="9010" xml_f="9011" txt_i="2640" txt_f="2641">-</offsets><xref rid="B24" ref-type="bibr"><offsets xml_i="9043" xml_f="9045" txt_i="2641" txt_f="2643">24</offsets></xref><offsets xml_i="9052" xml_f="9054" txt_i="2643" txt_f="2645">).</offsets></p><p><offsets xml_i="9061" xml_f="9326" txt_i="2646" txt_f="2911">These products are commercially available, their
quality is meticulously tested, and they are readyto-
use. Therefore the use of these high quality
products should significantly improve embryo
quality, cost-efficiency of the treatment, and the
clinicâ€™s reputation (</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="9358" xml_f="9360" txt_i="2911" txt_f="2913">12</offsets></xref><offsets xml_i="9367" xml_f="9369" txt_i="2913" txt_f="2915">).</offsets></p><p><offsets xml_i="9376" xml_f="9662" txt_i="2916" txt_f="3202">The purpose of this study was to compare
the efficiency of two different commercially
available media products (ISM1, MediCult,
Denmark vs. G-1TM v5, Vitrolife, Sweden) in
supporting the development of embryos (days
2 and 3), their ability to implant and deliver a
healthy baby at term.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="9713" xml_f="9734" txt_i="3204" txt_f="3225">Materials and Methods</offsets></title><sec><title><offsets xml_i="9754" xml_f="9772" txt_i="3226" txt_f="3244">Patient population</offsets></title><p><offsets xml_i="9783" xml_f="10353" txt_i="3245" txt_f="3815">
This prospective randomized study was performed
during a five month period (February-
June, 2009). During this period all culture
conditions, routines and disposables were kept
constant in the laboratory. On the day of oocyte
pick up, there were 583 patients randomized
to both groups according to a randomization
list based on sequential numbers in sealed envelopes.
The ISM1 group (experimental) consisted
of 293 patients compared to 290 patients
in the routine lab procedure group (control).
Depending on the causes of infertility, patients
received either standard </offsets><italic><offsets xml_i="10361" xml_f="10369" txt_i="3815" txt_f="3823">in vitro</offsets></italic><offsets xml_i="10378" xml_f="10735" txt_i="3823" txt_f="4180"> fertilization
(IVF) or intracytoplasmic sperm injection
(ICSI). Excluded from the study were patients
with previous fertilization failure [19 (experimental)
vs. 8 (control)]; those with no oocytes
retrieved [1 (experimental) vs. 1 (control)]; and
patients diagnosed with ovarian hyperstimulation
hormone syndrome [OHSS; 22 (experimental)
vs. 18 (control)].</offsets></p><p><offsets xml_i="10742" xml_f="10918" txt_i="4181" txt_f="4357">Inclusion criteria were counseling patients undergoing
ICSI treatment, between 18 to 40 years
of age who had a minimum of 2 follicles (â‰¥18 mm)
at the time of oocyte collection.</offsets></p><p><offsets xml_i="10925" xml_f="11310" txt_i="4358" txt_f="4743">Patients were randomly assigned to have their
fertilized oocytes cultured in ISM1 (MediCult,
cycles: n=293, written informed consent was
taken from all the couples who received this culture
medium) or routine lab procedure (G-1TM v5;
vitrolife, cycles: n=290) according to the daily
medium schedule for oocyte retrieval. This study
was approved by Ethical Committee of Royan
Institute.</offsets></p></sec><sec><title><offsets xml_i="11332" xml_f="11383" txt_i="4745" txt_f="4796">Stimulation regimes and oocyte retrieval techniques</offsets></title><p><offsets xml_i="11394" xml_f="11512" txt_i="4797" txt_f="4915">
Down regulation and ovarian stimulation were
performed in accordance with a previously reported
stimulation regimen (</offsets><xref rid="B25" ref-type="bibr"><offsets xml_i="11544" xml_f="11546" txt_i="4915" txt_f="4917">25</offsets></xref><offsets xml_i="11553" xml_f="11832" txt_i="4917" txt_f="5196">). In brief, pituitary
gonadotropin secretion was suppressed with
the GnRH agonist buserelin acetate (Suprefact,
Hoechst AG, Germany) via subcutaneous (SC) injection
(500 mg/d) or by nasal spray (800 mg/d)
starting in the mid luteal phase of the preceding
ovarian cycle (day 21).</offsets></p><p><offsets xml_i="11839" xml_f="12355" txt_i="5197" txt_f="5713">Once ovarian suppression was confirmed (serum
E2 â‰¤50 pg, FSH â‰¤12 IU and LH â‰¤5 IU), ovarian
stimulation was initiated with recombinant FSH
(Gonal F; SC injection, 150 IU/day, Serono, Switzerland).
The dose was adjusted according to the
response of the ovarian follicular development
and monitored by serial vaginal ultrasonography.
When at least three follicles reached 18 mm in
diameter, both GnRH agonist and hMG were discontinued
and a single dose of hCG (10000 IU;
Pregnyl; Organon, Netherlands) was administered.</offsets></p><p><offsets xml_i="12362" xml_f="12485" txt_i="5714" txt_f="5837">Oocyte retrieval was performed via vaginal ultrasound-
guided follicle aspiration, 36-38 hours
after administration of hCG.</offsets></p></sec><sec><title><offsets xml_i="12507" xml_f="12546" txt_i="5839" txt_f="5878">Intracytoplasmic sperm injection (ICSI)</offsets></title><p><offsets xml_i="12557" xml_f="13468" txt_i="5879" txt_f="6790">After egg collection, the cumulus-oocyte complexes were either placed in 50 Î¼L droplets
of Universal IVF medium and covered with
liquid paraffin (MediCult, Denmark) as the
experimental group or in 50 Î¼L droplets of
Hamâ€™s F-10, (Biochrom AG; Berlin, Germany),
which had been supplemented with 10%
recombinant human serum albumin (rHA, Vitrolife)
and covered with pre-incubated mineral
oil (Sigma, St. Louis, MO), as the control
group. Oocyte denudation was performed
with ICSI Cumulase (MediCult) in the experimental
group or with 80 IU of hyaluronidase,
(Sigma, USA) in the control group, two hours
after egg collection. Sperms were immobilized
in 10% PVP droplets (MediCult) in the experimental
group and in10% PVP droplets (Global)
in the control group by breaking the tail by
an injection pipette. Then, a single sperm with
head front was injected into each oocyte that
had a visible first polar body (MII) (</offsets><xref rid="B26" ref-type="bibr"><offsets xml_i="13500" xml_f="13502" txt_i="6790" txt_f="6792">26</offsets></xref><offsets xml_i="13509" xml_f="13511" txt_i="6792" txt_f="6794">, </offsets><xref rid="B27" ref-type="bibr"><offsets xml_i="13543" xml_f="13545" txt_i="6794" txt_f="6796">27</offsets></xref><offsets xml_i="13552" xml_f="13605" txt_i="6796" txt_f="6849">).
All semen samples were prepared by swim-up
method.</offsets></p></sec><sec><title><offsets xml_i="13627" xml_f="13670" txt_i="6851" txt_f="6894">Control of fertilization and embryo culture</offsets></title><p><offsets xml_i="13681" xml_f="14163" txt_i="6895" txt_f="7377">
The fertilization rate was controlled 18-20
hours after sperm injection. Normally fertilized
oocytes that had evidence of two pronuclei
were washed and transferred to overnight
pre-incubated in 20 Î¼l droplets of ISM1 or G-
1TM v5 supplemented with 10% recombinant
human serum albumin in the experimental and
control groups respectivly and covered with
either pre-incubated liquid paraffin (experimental
group) or mineral oil (control group).
All cultures incubated at 37ËšC, in 5% O</offsets><sub><offsets xml_i="14168" xml_f="14169" txt_i="7377" txt_f="7378">2</offsets></sub><offsets xml_i="14175" xml_f="14185" txt_i="7378" txt_f="7388"> and
6% CO</offsets><sub><offsets xml_i="14190" xml_f="14191" txt_i="7388" txt_f="7389">2</offsets></sub><offsets xml_i="14197" xml_f="14198" txt_i="7389" txt_f="7390">.</offsets></p></sec><sec><title><offsets xml_i="14220" xml_f="14258" txt_i="7392" txt_f="7430">Embryo scoring and transfer techniques</offsets></title><p><offsets xml_i="14269" xml_f="14403" txt_i="7431" txt_f="7565">
On the day of embryo transfer (44-72 hours after
injection), we scored embryo morphology according
to the following quality criteria:</offsets></p><list list-type="simple"><list-item><p><bold><offsets xml_i="14452" xml_f="14461" txt_i="7566" txt_f="7575">Excellent</offsets></bold></p></list-item><list-item><p><offsets xml_i="14498" xml_f="14554" txt_i="7576" txt_f="7632">Day 2: 2-4 even size blastomeres with â‰¤10% fragmentation</offsets></p></list-item><list-item><p><offsets xml_i="14584" xml_f="14640" txt_i="7633" txt_f="7689">Day 3: 6-8 even size blastomeres with â‰¤10% fragmentation</offsets></p></list-item><list-item><p><bold><offsets xml_i="14676" xml_f="14680" txt_i="7690" txt_f="7694">Good</offsets></bold></p></list-item><list-item><p><offsets xml_i="14717" xml_f="14786" txt_i="7695" txt_f="7764">Day 2: 2-4 even or uneven size blastomeres with
10%-20% fragmentation</offsets></p></list-item><list-item><p><offsets xml_i="14816" xml_f="14885" txt_i="7765" txt_f="7834">Day 3: 6-8 even or uneven size blastomeres with
10%-20% fragmentation</offsets></p></list-item><list-item><p><bold><offsets xml_i="14921" xml_f="14925" txt_i="7835" txt_f="7839">Poor</offsets></bold></p></list-item><list-item><p><offsets xml_i="14962" xml_f="15015" txt_i="7840" txt_f="7890">Uneven and few blastomeres with &gt;20% fragmentation</offsets></p></list-item></list><p><offsets xml_i="15041" xml_f="15333" txt_i="7891" txt_f="8183">Based upon the embryo quality, female age and
number of previous cycles, we selected a maximum
of four high quality embryos and incubated
them in UTM (MediCult) for the experimental
group or Embryo Glue (Vitrolife) for the control
group, for a period of 20-120 minutes before embryo
transfer.</offsets></p><p><offsets xml_i="15340" xml_f="15506" txt_i="8184" txt_f="8350">All embryo transfers were performed with a
Labotect catheter (Labotect, Germany) against a
filled urine bladder with the expertise of gynecologists
and embryologists.</offsets></p></sec><sec><title><offsets xml_i="15528" xml_f="15548" txt_i="8352" txt_f="8372">Statistical analysis</offsets></title><p><offsets xml_i="15559" xml_f="15933" txt_i="8373" txt_f="8744">
We used the Statistical Package for the Social
Sciences (SPSS 11.5; Chicago, IL, USA, http://
www.spss.com) software to analyze differences
amongst the variables of both groups by Chisquare
and Fisherâ€™s exact tests for categorical
variables or the studentâ€™s t test for continuous
variables, as appropriate. A p value &lt;0.05 was
considered to be statistically significant.</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="15980" xml_f="15987" txt_i="8747" txt_f="8754">Results</offsets></title><p><offsets xml_i="15998" xml_f="16252" txt_i="8755" txt_f="9009">Patient characteristics of the two groups are
summarized in table 1. The number of cycles,
mean female age, indications for infertility, number
of previous treatment cycles, retrieved oocytes
and percentage of cleaved embryos were similar in
both groups.</offsets></p><p><offsets xml_i="16259" xml_f="16704" txt_i="9010" txt_f="9452">There were no significant differences between
the groups in terms of cleavage rates, number
of embryos transferred, clinical pregnancy and
implantation rates and multiple pregnancies.
There were a significantly higher percentage
of excellent embryos in the experimental group
(42.7%; ISM1) compared to the control group
(39%, p&lt;0.05). There was also a trend towards
higher clinical and multiple pregnancy rates as
well as implantation rates (</offsets><xref ref-type="table" rid="T2"><offsets xml_i="16736" xml_f="16743" txt_i="9452" txt_f="9459">Table 2</offsets></xref><offsets xml_i="16750" xml_f="16779" txt_i="9459" txt_f="9488">) for the experimental
group.</offsets></p><p><offsets xml_i="16786" xml_f="17220" txt_i="9489" txt_f="9920">In terms of abortion, the experimental group (20.5%) was not significantly different from the
control group (21.1%). There was no significant
difference in baby take home rates (BTHR) between
both groups, however both the length [48.8
cm (experimental) vs. 46.0 cm (control)] and weight
[3.03 kg (experimental) vs. 2.66 kg (control)] of babies
born were significantly higher in the expreimental
group (p&lt;0.001 for both parameters).</offsets></p><table-wrap id="T1" orientation="portrait" position="float"><label><offsets xml_i="17291" xml_f="17298" txt_i="9921" txt_f="9928">Table 1</offsets></label><caption><p><offsets xml_i="17318" xml_f="17416" txt_i="9928" txt_f="10026">Patientsâ€™ ART cycle characteristics in the MediCult (experimental) and lab routine media (control)</offsets></p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr></hr></th></tr><tr><th rowspan="1" colspan="1"><offsets xml_i="17557" xml_f="17567" txt_i="10027" txt_f="10037">Parameters</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="17600" xml_f="17618" txt_i="10037" txt_f="10055">Experimental group</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="17651" xml_f="17664" txt_i="10055" txt_f="10068">Control group</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="17697" xml_f="17704" txt_i="10068" txt_f="10075">P value</offsets></th></tr><tr><th colspan="4" rowspan="1"><hr></hr></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="17816" xml_f="17829" txt_i="10075" txt_f="10088">No. of cycles</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="17869" xml_f="17872" txt_i="10089" txt_f="10092">293</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17905" xml_f="17908" txt_i="10093" txt_f="10096">290</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17941" xml_f="17945" txt_i="10097" txt_f="10101">0.37</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="18006" xml_f="18032" txt_i="10102" txt_f="10128">Female age (Y) (mean Â± SD)</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="18072" xml_f="18082" txt_i="10129" txt_f="10139">32.4 Â± 5.7</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18115" xml_f="18125" txt_i="10140" txt_f="10150">31.8 Â± 5.6</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18158" xml_f="18162" txt_i="10151" txt_f="10155">0.18</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="18223" xml_f="18246" txt_i="10156" txt_f="10179">Male factor infertility</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="18286" xml_f="18299" txt_i="10180" txt_f="10193">170/293 (58%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18332" xml_f="18347" txt_i="10194" txt_f="10209">170/290 (58.6%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18380" xml_f="18384" txt_i="10210" txt_f="10214">0.88</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="18445" xml_f="18470" txt_i="10215" txt_f="10240">Female factor infertility</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="18510" xml_f="18524" txt_i="10241" txt_f="10255">66/293 (22.5%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18557" xml_f="18571" txt_i="10256" txt_f="10270">62/290 (21.4%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18604" xml_f="18609" txt_i="10271" txt_f="10276"> 0.73</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="18670" xml_f="18688" txt_i="10277" txt_f="10295"> Mixed infertility</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="18728" xml_f="18740" txt_i="10296" txt_f="10308">44/293 (15%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18773" xml_f="18785" txt_i="10309" txt_f="10321">46/290 (16%)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18818" xml_f="18822" txt_i="10322" txt_f="10326">0.77</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="18883" xml_f="18906" txt_i="10327" txt_f="10350">Unexplained infertility</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="18946" xml_f="18960" txt_i="10351" txt_f="10365">13/293 (4.4%) </offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18993" xml_f="19007" txt_i="10366" txt_f="10380">12/290 (4.1%) </offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19040" xml_f="19044" txt_i="10381" txt_f="10385">0.83</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="19105" xml_f="19136" txt_i="10386" txt_f="10417">Previous ART cycles (mean Â± SD)</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="19176" xml_f="19185" txt_i="10418" txt_f="10427">1.7 Â± 1.2</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19218" xml_f="19227" txt_i="10428" txt_f="10437">1.8 Â± 1.0</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19260" xml_f="19264" txt_i="10438" txt_f="10442">0.21</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="19325" xml_f="19362" txt_i="10443" txt_f="10480"> No. of retrieved oocytes (mean Â± SD)</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="19402" xml_f="19411" txt_i="10481" txt_f="10490">9.1 Â± 5.6</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19444" xml_f="19453" txt_i="10491" txt_f="10500">8.8 Â± 5.1</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="19486" xml_f="19490" txt_i="10501" txt_f="10505">0.52</offsets></td></tr><tr><th colspan="4" rowspan="1"><hr></hr></th></tr></tbody></table></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label><offsets xml_i="19647" xml_f="19654" txt_i="10506" txt_f="10513">Table 2</offsets></label><caption><p><offsets xml_i="19674" xml_f="19812" txt_i="10513" txt_f="10651">Fertilization, cleaved embryo, embryo quality and clinical pregnancy in the MediCult (experimental) and lab routine
media (control) groups</offsets></p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr></hr></th></tr><tr><th rowspan="1" colspan="1"><offsets xml_i="19953" xml_f="19963" txt_i="10652" txt_f="10662">Parameters</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="19996" xml_f="20014" txt_i="10662" txt_f="10680">Experimental group</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="20047" xml_f="20060" txt_i="10680" txt_f="10693">Control group</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="20093" xml_f="20101" txt_i="10693" txt_f="10701">*P value</offsets></th></tr><tr><th colspan="4" rowspan="1"><hr></hr></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="20213" xml_f="20226" txt_i="10701" txt_f="10714">Cleavage rate</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="20266" xml_f="20281" txt_i="10715" txt_f="10730">86% (1471/1706)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20314" xml_f="20329" txt_i="10731" txt_f="10746">88% (1455/1678)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20362" xml_f="20366" txt_i="10747" txt_f="10751">0.68</offsets></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold><offsets xml_i="20427" xml_f="20441" txt_i="10752" txt_f="10766">Embryo quality</offsets></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="20509" xml_f="20518" txt_i="10767" txt_f="10776">Excellent</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="20558" xml_f="20567" txt_i="10777" txt_f="10786">43% (628)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20600" xml_f="20609" txt_i="10787" txt_f="10796">39% (567)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20642" xml_f="20647" txt_i="10797" txt_f="10802">0.04a</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="20708" xml_f="20712" txt_i="10803" txt_f="10807">Good</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="20752" xml_f="20761" txt_i="10808" txt_f="10817">39% (580)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20794" xml_f="20803" txt_i="10818" txt_f="10827">41% (599)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20836" xml_f="20840" txt_i="10828" txt_f="10832">0.33</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="20901" xml_f="20905" txt_i="10833" txt_f="10837">Poor</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="20945" xml_f="20954" txt_i="10838" txt_f="10847">18% (261)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="20987" xml_f="20996" txt_i="10848" txt_f="10857">20% (288)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21029" xml_f="21033" txt_i="10858" txt_f="10862">0.15</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21094" xml_f="21132" txt_i="10863" txt_f="10901">No. of transferred embryos (mean Â± SD)</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="21172" xml_f="21181" txt_i="10902" txt_f="10911">2.4 Â± 0.8</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21214" xml_f="21223" txt_i="10912" txt_f="10921">2.4 Â± 0.8</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21256" xml_f="21260" txt_i="10922" txt_f="10926">0.83</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21321" xml_f="21360" txt_i="10927" txt_f="10966">Clinical pregnancy rate/embryo transfer</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="21400" xml_f="21414" txt_i="10967" txt_f="10981">32.1% (94/293)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21447" xml_f="21461" txt_i="10982" txt_f="10996">27.6% (80/290)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21494" xml_f="21498" txt_i="10997" txt_f="11001">0.23</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21559" xml_f="21576" txt_i="11002" txt_f="11019">Implantation rate</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="21616" xml_f="21629" txt_i="11020" txt_f="11033">15% (102/697)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21662" xml_f="21674" txt_i="11034" txt_f="11046">12% (84/693)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21707" xml_f="21711" txt_i="11047" txt_f="11051">0.16</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21772" xml_f="21795" txt_i="11052" txt_f="11075">Multiple pregnancy rate</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="21835" xml_f="21846" txt_i="11076" txt_f="11087">8.5% (8/94)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21879" xml_f="21890" txt_i="11088" txt_f="11099">3.8% (3/80)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="21923" xml_f="21927" txt_i="11100" txt_f="11104">0.19</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21988" xml_f="21994" txt_i="11105" txt_f="11111">Single</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="22034" xml_f="22047" txt_i="11112" txt_f="11125">91.5% (86/94)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="22080" xml_f="22093" txt_i="11126" txt_f="11139">96.2% (77/80)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="22126" xml_f="22130" txt_i="11140" txt_f="11144">0.19</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="22191" xml_f="22195" txt_i="11145" txt_f="11149">Twin</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="22235" xml_f="22246" txt_i="11150" txt_f="11161">8.5% (8/94)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="22279" xml_f="22290" txt_i="11162" txt_f="11173">2.5% (2/80)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="22323" xml_f="22327" txt_i="11174" txt_f="11178">0.09</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="22388" xml_f="22395" txt_i="11179" txt_f="11186">Triplet</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="22435" xml_f="22444" txt_i="11187" txt_f="11196">0% (0/94)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="22477" xml_f="22488" txt_i="11197" txt_f="11208">1.3% (1/80)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="22521" xml_f="22525" txt_i="11209" txt_f="11213">0.46</offsets></td></tr><tr><th colspan="4" rowspan="1"><hr></hr></th></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="22626" xml_f="22717" txt_i="11214" txt_f="11305">a; Statistically significant differences between the two groups and *; Fisherâ€™s exact test.</offsets></p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label><offsets xml_i="22824" xml_f="22831" txt_i="11306" txt_f="11313">Table 3</offsets></label><caption><p><offsets xml_i="22851" xml_f="22971" txt_i="11313" txt_f="11433">Clinical outcome, abortion and take-home baby rate in the MediCult (experimental) and lab routine media (control) groups</offsets></p></caption><table frame="hsides" rules="groups"><tbody><tr><th colspan="4" rowspan="1"><hr></hr></th></tr><tr><th rowspan="1" colspan="1"><offsets xml_i="23112" xml_f="23122" txt_i="11434" txt_f="11444">Parameters</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="23155" xml_f="23173" txt_i="11444" txt_f="11462">Experimental group</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="23206" xml_f="23219" txt_i="11462" txt_f="11475">Control group</offsets></th><th rowspan="1" colspan="1"><offsets xml_i="23252" xml_f="23260" txt_i="11475" txt_f="11483">*P value</offsets></th></tr><tr><th colspan="4" rowspan="1"><hr></hr></th></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="23372" xml_f="23385" txt_i="11483" txt_f="11496">Abortion rate</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="23425" xml_f="23438" txt_i="11497" txt_f="11510">20.5% (18/88)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="23471" xml_f="23484" txt_i="11511" txt_f="11524">21.1% (16/76)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="23517" xml_f="23520" txt_i="11525" txt_f="11528">0.9</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="23581" xml_f="23597" txt_i="11529" txt_f="11545">First trimester </offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="23637" xml_f="23650" txt_i="11546" txt_f="11559">77.8% (14/18)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="23683" xml_f="23696" txt_i="11560" txt_f="11573">87.5% (14/16)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="23729" xml_f="23733" txt_i="11574" txt_f="11578">0.58</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="23794" xml_f="23811" txt_i="11579" txt_f="11596">Second trimester </offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="23851" xml_f="23864" txt_i="11597" txt_f="11610"> 16.7% (3/18)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="23897" xml_f="23910" txt_i="11611" txt_f="11624"> 12.5% (2/16)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="23943" xml_f="23947" txt_i="11625" txt_f="11629">0.48</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24008" xml_f="24024" txt_i="11630" txt_f="11646">Third trimester </offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="24064" xml_f="24075" txt_i="11647" txt_f="11658">5.5% (1/18)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24108" xml_f="24117" txt_i="11659" txt_f="11668">0% (0/16)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24150" xml_f="24154" txt_i="11669" txt_f="11673">0.35</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24215" xml_f="24242" txt_i="11674" txt_f="11701">Baby take home rate (BTHR) </offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="24282" xml_f="24296" txt_i="11702" txt_f="11716">84.3% (86/102)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24329" xml_f="24343" txt_i="11717" txt_f="11731"> 80.4% (78/97)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24376" xml_f="24380" txt_i="11732" txt_f="11736">0.57</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24441" xml_f="24464" txt_i="11737" txt_f="11760">Multiple pregnancy rate</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="24504" xml_f="24515" txt_i="11761" txt_f="11772">8.5% (8/94)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24548" xml_f="24559" txt_i="11773" txt_f="11784">3.8% (3/80)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24592" xml_f="24597" txt_i="11785" txt_f="11790"> 0.19</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24658" xml_f="24665" txt_i="11791" txt_f="11798">Single </offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="24705" xml_f="24719" txt_i="11799" txt_f="11813">78.9% (56/71) </offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24752" xml_f="24766" txt_i="11814" txt_f="11828"> 66.7% (40/60)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24799" xml_f="24802" txt_i="11829" txt_f="11832">0.1</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24863" xml_f="24868" txt_i="11833" txt_f="11838">Twin </offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="24908" xml_f="24922" txt_i="11839" txt_f="11853">21.1% (15/71) </offsets></td><td rowspan="1" colspan="1"><offsets xml_i="24955" xml_f="24968" txt_i="11854" txt_f="11867">31.7% (19/60)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25001" xml_f="25004" txt_i="11868" txt_f="11871">0.1</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25065" xml_f="25072" txt_i="11872" txt_f="11879">Triplet</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="25112" xml_f="25121" txt_i="11880" txt_f="11889">0% (0/71)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25154" xml_f="25166" txt_i="11890" txt_f="11902">1.7% (1/60) </offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25199" xml_f="25202" txt_i="11903" txt_f="11906">0.1</offsets></td></tr><tr><td align="left" colspan="4" rowspan="1"><bold><offsets xml_i="25263" xml_f="25266" txt_i="11907" txt_f="11910">Sex</offsets></bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25334" xml_f="25338" txt_i="11911" txt_f="11915">Male</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="25378" xml_f="25391" txt_i="11916" txt_f="11929">44.1% (38/86)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25424" xml_f="25437" txt_i="11930" txt_f="11943">51.3% (40/78)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25470" xml_f="25473" txt_i="11944" txt_f="11947">0.3</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25534" xml_f="25540" txt_i="11948" txt_f="11954">Female</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="25580" xml_f="25593" txt_i="11955" txt_f="11968">55.8% (48/86)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25626" xml_f="25639" txt_i="11969" txt_f="11982">48.7% (38/78)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25672" xml_f="25675" txt_i="11983" txt_f="11986">0.3</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25736" xml_f="25758" txt_i="11987" txt_f="12009">Length (cm, mean Â± SD)</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="25798" xml_f="25809" txt_i="12010" txt_f="12021">48.8 Â± 0.52</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25842" xml_f="25853" txt_i="12022" txt_f="12033">46.0 Â± 0.66</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="25886" xml_f="25893" txt_i="12034" txt_f="12041">0.001 a</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25954" xml_f="25975" txt_i="12042" txt_f="12063">Weight (kg, mean Â± D)</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="26015" xml_f="26026" txt_i="12064" txt_f="12075">3.03 Â± 0.07</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26059" xml_f="26070" txt_i="12076" txt_f="12087">2.66 Â± 0.08</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="26103" xml_f="26110" txt_i="12088" txt_f="12095">0.001 a</offsets></td></tr><tr><th colspan="4" rowspan="1"><hr></hr></th></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="26211" xml_f="26289" txt_i="12096" txt_f="12174">a; Statistically significant differences between the two groups and *; t test.</offsets></p><p><offsets xml_i="26296" xml_f="26439" txt_i="12175" txt_f="12318">Of all pregnant patients, 10 (n=6 for expreimental group and n=4 for control group) patients were not available and were
excluded from table 3.</offsets></p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title><offsets xml_i="26519" xml_f="26529" txt_i="12320" txt_f="12330">Discussion</offsets></title><p><offsets xml_i="26540" xml_f="26573" txt_i="12331" txt_f="12364">There are a variety of different </offsets><italic><offsets xml_i="26581" xml_f="26589" txt_i="12364" txt_f="12372">in vitro</offsets></italic><offsets xml_i="26598" xml_f="26923" txt_i="12372" txt_f="12697"> culture
systems available for laboratory procedures applied
to gamete maintenance and embryonic
growth. These media products range from simple
solutions to more complex culture media systems,
which have been adapted to the changes that the
developing embryos face during their passage
through the female reproductive tract (</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="26955" xml_f="26957" txt_i="12697" txt_f="12699">11</offsets></xref><offsets xml_i="26964" xml_f="26965" txt_i="12699" txt_f="12700">-</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="26997" xml_f="26999" txt_i="12700" txt_f="12702">13</offsets></xref><offsets xml_i="27006" xml_f="27414" txt_i="12702" txt_f="13110">).
Many recent discoveries have been fundamental
in describing different biochemical, physiologic,
genetic, and epigenetic characteristics of the embryo,
resulting in recent innovations in this field.
Culture media formulations are presumed to be of
essential importance for normal development of
human embryos in the controlled environment of
an incubatorin addition to their effects on developing
embryos (</offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="27446" xml_f="27448" txt_i="13110" txt_f="13112">22</offsets></xref><offsets xml_i="27455" xml_f="27457" txt_i="13112" txt_f="13114">, </offsets><xref rid="B23" ref-type="bibr"><offsets xml_i="27489" xml_f="27491" txt_i="13114" txt_f="13116">23</offsets></xref><offsets xml_i="27498" xml_f="27500" txt_i="13116" txt_f="13118">, </offsets><xref rid="B28" ref-type="bibr"><offsets xml_i="27532" xml_f="27534" txt_i="13118" txt_f="13120">28</offsets></xref><offsets xml_i="27541" xml_f="27543" txt_i="13120" txt_f="13122">).</offsets></p><p><offsets xml_i="27550" xml_f="27644" txt_i="13123" txt_f="13217">A general agreement does not exist regarding
the efficacy of different commercially available
</offsets><italic><offsets xml_i="27652" xml_f="27660" txt_i="13217" txt_f="13225">in vitro</offsets></italic><offsets xml_i="27669" xml_f="27786" txt_i="13225" txt_f="13342"> culture media, since some studies have
reported no differences in embryo quality, pregnancy
and implantation rates (</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="27818" xml_f="27820" txt_i="13342" txt_f="13344">18</offsets></xref><offsets xml_i="27827" xml_f="27829" txt_i="13344" txt_f="13346">, </offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="27861" xml_f="27863" txt_i="13346" txt_f="13348">21</offsets></xref><offsets xml_i="27870" xml_f="27872" txt_i="13348" txt_f="13350">, </offsets><xref rid="B29" ref-type="bibr"><offsets xml_i="27904" xml_f="27906" txt_i="13350" txt_f="13352">29</offsets></xref><offsets xml_i="27913" xml_f="28027" txt_i="13352" txt_f="13466">), whereas
others have observed subtle differences in day 3
embryo quality [G1.2 vs. Sydney IVF sequential
media (</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="28059" xml_f="28061" txt_i="13466" txt_f="13468">16</offsets></xref><offsets xml_i="28068" xml_f="28085" txt_i="13468" txt_f="13485">), G1.2 vs. HTF (</offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="28117" xml_f="28119" txt_i="13485" txt_f="13487">20</offsets></xref><offsets xml_i="28126" xml_f="28156" txt_i="13487" txt_f="13517">) and GIII series versus
ISM1(</offsets><xref rid="B30" ref-type="bibr"><offsets xml_i="28188" xml_f="28190" txt_i="13517" txt_f="13519">30</offsets></xref><offsets xml_i="28197" xml_f="28200" txt_i="13519" txt_f="13522">)].</offsets></p><p><offsets xml_i="28207" xml_f="28436" txt_i="13523" txt_f="13752">Several studies have investigated the effect of
ISM1 and G-1TM v5 media on embryo quality and
implantation rate. Embryo morphology on days 2
and 3 significantly enhanced when the embryos
were cultured in GIII series versus ISM1 (</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="28468" xml_f="28470" txt_i="13752" txt_f="13754">18</offsets></xref><offsets xml_i="28477" xml_f="28671" txt_i="13754" txt_f="13948">).
Another study showed that "in a day 3 embryo
transfer program, G1.2/G2.2 media were superior
to Sydney IVF media, whereas both media yielded
similar outcomes in blastocyst transfer program"
(</offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="28703" xml_f="28705" txt_i="13948" txt_f="13950">20</offsets></xref><offsets xml_i="28712" xml_f="28714" txt_i="13950" txt_f="13952">).</offsets></p><p><offsets xml_i="28721" xml_f="28946" txt_i="13953" txt_f="14178">A prospective study on sibling oocytes showed
that embryo quality in the day 2 stage improved
under ISM1 culture rather than FertiCult culture
medium, even if data regarding pregnancy and
implantation rate were not reported (</offsets><xref rid="B31" ref-type="bibr"><offsets xml_i="28978" xml_f="28980" txt_i="14178" txt_f="14180">31</offsets></xref><offsets xml_i="28987" xml_f="29165" txt_i="14180" txt_f="14358">). Another
study demonstrated that ISM1 culture medium
seemed to improve the performance of embryonic growth and development, as well as increased the
percentage of pregnancies (</offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="29197" xml_f="29199" txt_i="14358" txt_f="14360">32</offsets></xref><offsets xml_i="29206" xml_f="29208" txt_i="14360" txt_f="14362">).</offsets></p><p><offsets xml_i="29215" xml_f="29470" txt_i="14363" txt_f="14618">For this reason, we conducted a prospective randomized
trial at Royan Institute to compare embryo
development parameters, IVF outcome and
BTHR at the end of the gestational period between
ISM1 and G-1TM v5 media, which is used routinely
in our laboratory.</offsets></p><p><offsets xml_i="29477" xml_f="29565" txt_i="14619" txt_f="14707">The result of the study suggests that both ISM1
and G-1TM v5 support embryo development </offsets><italic><offsets xml_i="29573" xml_f="29581" txt_i="14707" txt_f="14715">in vitro</offsets></italic><offsets xml_i="29590" xml_f="29671" txt_i="14715" txt_f="14796">,
whereas culture in ISM1 gives a higher proportion
of excellent quality embryos.</offsets></p><p><offsets xml_i="29678" xml_f="30306" txt_i="14797" txt_f="15425">Good embryo quality, cleavage rate, and single,
triplet pregnancy rate in the control group were
higher than ISM1 medium, but there were no significant
differences. In ISM1, the implantation,
clinical pregnancy and twin pregnancy rates were
higher than the G-1TM v5 medium. However, this
difference was not significant. The percentage of
excellent embryos was significantly higher than
the control group which might be reflected in the
characteristics of babies born. Babies born after
culture in ISM1 had both significantly higher birth
weight and were also longer compared to the control
group, both of which were significant.</offsets></p><p><offsets xml_i="30313" xml_f="30332" txt_i="15426" txt_f="15445">In vivo as well as </offsets><italic><offsets xml_i="30340" xml_f="30348" txt_i="15445" txt_f="15453">in vitro</offsets></italic><offsets xml_i="30357" xml_f="30548" txt_i="15453" txt_f="15644"> fundamental factors for
proper embryonic development could be summarized
as oxygen consumption, the balance between
reactive oxygen species and antioxidant defense,
energetic metabolites (Na</offsets><sup><offsets xml_i="30553" xml_f="30554" txt_i="15644" txt_f="15645">+</offsets></sup><offsets xml_i="30560" xml_f="30563" txt_i="15645" txt_f="15648">, K</offsets><sup><offsets xml_i="30568" xml_f="30569" txt_i="15648" txt_f="15649">+</offsets></sup><offsets xml_i="30575" xml_f="30776" txt_i="15649" txt_f="15850">, adenosine triphosphatase),
and amino acid turnover. The oxygen
requirement appears constant over the course of
the early embryonic development phases up to the
blastocyst stage, and later increases (</offsets><xref rid="B33" ref-type="bibr"><offsets xml_i="30808" xml_f="30810" txt_i="15850" txt_f="15852">33</offsets></xref><offsets xml_i="30817" xml_f="30819" txt_i="15852" txt_f="15854">).</offsets></p><p><offsets xml_i="30826" xml_f="30982" txt_i="15855" txt_f="16011">Although in vivo physiologic reactive oxygen
species production is controlled continuously by
a strong cellular defense, the lack of this system
during the </offsets><italic><offsets xml_i="30990" xml_f="30998" txt_i="16011" txt_f="16019">in vitro</offsets></italic><offsets xml_i="31007" xml_f="31137" txt_i="16019" txt_f="16149"> culture could cause oxidation
of proteins, lipids, DNA, and the misregulation
of metabolic pathways that may lead to cell death
(</offsets><xref rid="B34" ref-type="bibr"><offsets xml_i="31169" xml_f="31171" txt_i="16149" txt_f="16151">34</offsets></xref><offsets xml_i="31178" xml_f="31179" txt_i="16151" txt_f="16152">-</offsets><xref rid="B36" ref-type="bibr"><offsets xml_i="31211" xml_f="31213" txt_i="16152" txt_f="16154">36</offsets></xref><offsets xml_i="31220" xml_f="31472" txt_i="16154" txt_f="16406">). On the basis of these observations, it can
be speculated that the antioxidant elements present
in ISM1 culture medium sustain the cultured
embryos, thereby avoiding developmental failure
and also achieving the best quality embryos
for implantation (</offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="31504" xml_f="31506" txt_i="16406" txt_f="16408">32</offsets></xref><offsets xml_i="31513" xml_f="31812" txt_i="16408" txt_f="16707">). The result of this study has
demonstrated that ISM1 medium improved embryo
development. The percentage of excellent
embryos was significantly higher in ISM1 medium
compared with the control group (G-1TM v5). This
result was possibly due to the antioxidant elements
present in ISM1 culture medium.</offsets></p><p><offsets xml_i="31819" xml_f="31944" txt_i="16708" txt_f="16833">Singleton children born after IVF have a significantly
lower birth weight compared with their
spontaneously conceived peers (</offsets><xref rid="B37" ref-type="bibr"><offsets xml_i="31976" xml_f="31978" txt_i="16833" txt_f="16835">37</offsets></xref><offsets xml_i="31985" xml_f="31986" txt_i="16835" txt_f="16836">-</offsets><xref rid="B39" ref-type="bibr"><offsets xml_i="32018" xml_f="32020" txt_i="16836" txt_f="16838">39</offsets></xref><offsets xml_i="32027" xml_f="32209" txt_i="16838" txt_f="17020">), even after
adjustments for maternal age and parity. This
phenomenon has produced concern, because low
birth weight is associated with morbidity over both
the short and long term (</offsets><xref rid="B40" ref-type="bibr"><offsets xml_i="32241" xml_f="32243" txt_i="17020" txt_f="17022">40</offsets></xref><xref rid="B41" ref-type="bibr"><offsets xml_i="32282" xml_f="32284" txt_i="17022" txt_f="17024">41</offsets></xref><offsets xml_i="32291" xml_f="32646" txt_i="17024" txt_f="17379">).
Theoretically the lower birth weight in IVF singletons
could be attributed to i. maternal and/or
paternal characteristics associated with infertility;
ii. the effects of ovarian stimulation on oocytes, endometrium
or the endocrinology of the luteal phase
or early pregnancy; or iii. IVF laboratory procedures
such as ICSI or embryo culture conditions (</offsets><xref rid="B42" ref-type="bibr"><offsets xml_i="32678" xml_f="32680" txt_i="17379" txt_f="17381">42</offsets></xref><offsets xml_i="32687" xml_f="32689" txt_i="17381" txt_f="17383">, </offsets><xref rid="B43" ref-type="bibr"><offsets xml_i="32721" xml_f="32723" txt_i="17383" txt_f="17385">43</offsets></xref><offsets xml_i="32730" xml_f="32920" txt_i="17385" txt_f="17575">).
The implementation of suitable quality control has
focused on the effectiveness of culture media in improving
embryo morphology and it is fundamental to
the success of an IVF laboratory (</offsets><xref rid="B44" ref-type="bibr"><offsets xml_i="32952" xml_f="32954" txt_i="17575" txt_f="17577">44</offsets></xref><offsets xml_i="32961" xml_f="32963" txt_i="17577" txt_f="17579">).</offsets></p><p><offsets xml_i="32970" xml_f="33241" txt_i="17580" txt_f="17851">"The possible interference of assisted reproduction
techniques (ART) with epigenetic reprogramming
during early embryo development has recently
sparked renewed interest about the reported
lower birth weight among infants born as a consequence
of infertility treatments" (</offsets><xref rid="B45" ref-type="bibr"><offsets xml_i="33273" xml_f="33275" txt_i="17851" txt_f="17853">45</offsets></xref><offsets xml_i="33282" xml_f="33284" txt_i="17853" txt_f="17855">).</offsets></p><p><offsets xml_i="33291" xml_f="33692" txt_i="17856" txt_f="18257">Both the shorter duration of pregnancy and the
reduced neonatal birth weight could be caused by
inactivation of paternal alleles during the imprinting
process. If the shorter duration of pregnancy
and the lower birth weight after IVF and ICSI can
be attributed to a distinct defect of epigenetic phenomena
at work during parental imprinting, then
this defect may have later effects on the individual
(</offsets><xref rid="B46" ref-type="bibr"><offsets xml_i="33724" xml_f="33726" txt_i="18257" txt_f="18259">46</offsets></xref><offsets xml_i="33733" xml_f="33735" txt_i="18259" txt_f="18261">, </offsets><xref rid="B47" ref-type="bibr"><offsets xml_i="33767" xml_f="33769" txt_i="18261" txt_f="18263">47</offsets></xref><offsets xml_i="33776" xml_f="33840" txt_i="18263" txt_f="18327">) and has the potential to be transferred to
other generations (</offsets><xref rid="B48" ref-type="bibr"><offsets xml_i="33872" xml_f="33874" txt_i="18327" txt_f="18329">48</offsets></xref><offsets xml_i="33881" xml_f="33883" txt_i="18329" txt_f="18331">).</offsets></p><p><offsets xml_i="33890" xml_f="34006" txt_i="18332" txt_f="18448">ISM1 culture medium was formulated to promote
correct imprinting for ensuring correct development
and implantation (</offsets><xref rid="B32" ref-type="bibr"><offsets xml_i="34038" xml_f="34040" txt_i="18448" txt_f="18450">32</offsets></xref><offsets xml_i="34047" xml_f="34085" txt_i="18450" txt_f="18488">). As demonstrated
by Cassuto et al. (</offsets><xref rid="B49" ref-type="bibr"><offsets xml_i="34117" xml_f="34119" txt_i="18488" txt_f="18490">49</offsets></xref><offsets xml_i="34126" xml_f="34498" txt_i="18490" txt_f="18862">), different timing and culture
conditions can have different effects on embryo
development and implantation rate. Extended culture
time and particular culture conditions result in
an increase in monozygotic twinning. In this study
the use of only ISM1/ISM2 culture conditions resulted
in lower monozygotic twin pregnancies, independent of the technology used (IVF/ICSI)
(</offsets><xref rid="B49" ref-type="bibr"><offsets xml_i="34530" xml_f="34532" txt_i="18862" txt_f="18864">49</offsets></xref><offsets xml_i="34539" xml_f="34794" txt_i="18864" txt_f="19119">). The result of our study demonstrated that
babies born after culture in ISM1 had both higher
birth weight and were also longer than those in
control group. This result might be due to correct
imprinting that ensured correct development and
implantation.</offsets></p></sec><sec sec-type="conclusions"><title><offsets xml_i="34839" xml_f="34849" txt_i="19121" txt_f="19131">Conclusion</offsets></title><p><offsets xml_i="34860" xml_f="35550" txt_i="19132" txt_f="19822">This study suggests that on the one hand ISM1
contains antioxidant elements and on the other
hand it is formulated to promote correct imprinting
to ensure correct development and implantation.
ISM1 is presumed to be a more effective culture
medium that generates higher quality embryos,
which is reflected in the characteristics of babies
born. Since numerous factors that include motherâ€™s
diabetes and multiple pregnancies, among others
may also impact the height and the weight of the
newborn, we cannot directly relate the change in
these two characteristics solely to the culture media.
For reaching a definitive conclusion, additional
studies that consider these factors are warranted.</offsets></p></sec></body><back><ack><p>The authors would like to express their appreciation
to Origio Company for its support in addition to
Drs. Vosooghi and Abolghasemi for their unwavering
support. We also are grateful to Mr. Dalman for
his help in editing this article. The authors have no
financial interests or any other conflicts of interest.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijs</surname><given-names>M</given-names></name><name><surname>Creemers</surname><given-names>E</given-names></name><name><surname>Cox</surname><given-names>A</given-names></name><name><surname>Janssen</surname><given-names>M</given-names></name><name><surname>Vanheusden</surname><given-names>E</given-names></name><name><surname>Van der</surname><given-names>Elst J</given-names></name><etal></etal></person-group><article-title>Relationship between hyaluronic acid binding assay and outcome in ART: a pilot study</article-title><source>Andrologia</source><year>2010</year><volume>42</volume><issue>5</issue><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">20860626</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben -Yousef</surname><given-names>D</given-names></name><name><surname>Amit</surname><given-names>A</given-names></name><name><surname>Azem</surname><given-names>F</given-names></name><name><surname>Schwartsz</surname><given-names>T</given-names></name><name><surname>Cohen</surname><given-names>T</given-names></name><name><surname>Mei-Raz</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Prospective randomized comparison of two embryo culture systems: P1 medium by Irvine Scientific and the cook IVF medium</article-title><source>J Assist Reprod Genet</source><year>2004</year><volume>21</volume><issue>8</issue><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">15568329</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderam</surname><given-names>S</given-names></name><name><surname>Kissin</surname><given-names>DM</given-names></name><name><surname>Flowers</surname><given-names>L</given-names></name><name><surname>Anderson</surname><given-names>JE</given-names></name><name><surname>Folger</surname><given-names>SG</given-names></name><name><surname>Jamieson</surname><given-names>DJ</given-names></name><etal></etal></person-group><article-title>Assisted reproductive technology surveillance-United States, 2009</article-title><source>MMWR Surveill Summ</source><year>2012</year><volume>61</volume><issue>7</issue><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">23114281</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratnam</surname><given-names>SS</given-names></name><name><surname>Devendra</surname><given-names>S</given-names></name><name><surname>Marshall</surname><given-names>B</given-names></name><name><surname>Anandkumar</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>YC</given-names></name><name><surname>Goh</surname><given-names>HH</given-names></name><etal></etal></person-group><article-title>Stimulation regimens in assisted reproductive technology (ART) programme: experience in the University Hospital, Singapore</article-title><source>Ann Acad Med Singapore</source><year>1993</year><volume>22</volume><issue>3</issue><fpage>351</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">8373118</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinori</surname><given-names>M</given-names></name><name><surname>Licata</surname><given-names>E</given-names></name><name><surname>Dani</surname><given-names>G</given-names></name><name><surname>Cerusico</surname><given-names>F</given-names></name><name><surname>Versaci</surname><given-names>C</given-names></name><name><surname>d'Angelo</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Intracytoplasmic morphologically selected sperm injection: a prospective randomized trial</article-title><source>Reprod Biomed Online</source><year>2008</year><volume>16</volume><issue>6</issue><fpage>835</fpage><lpage>841</lpage><pub-id pub-id-type="pmid">18549694</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>JE</given-names></name><name><surname>Pool</surname><given-names>TB</given-names></name></person-group><article-title>New pH-buffering system for media utilized during gamete and embryo manipulations for assisted reproduction</article-title><source>Reprod Biomed Online</source><year>2009</year><volume>18</volume><issue>6</issue><fpage>779</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">19490784</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacic</surname><given-names>B</given-names></name><name><surname>Sajko</surname><given-names>MC</given-names></name><name><surname>VlaisavljeviÄ‡</surname><given-names>V</given-names></name></person-group><article-title>A prospective, randomized trial on the effect of atmospheric versus reduced oxygen concentration on the outcome of intracytoplasmic sperm injection cycles</article-title><source>Fertil Steril</source><year>2010</year><volume>94</volume><issue>2</issue><fpage>511</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">19409544</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebner</surname><given-names>T</given-names></name><name><surname>Shebl</surname><given-names>O</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Mayer</surname><given-names>RB</given-names></name><name><surname>Arzt</surname><given-names>W</given-names></name><name><surname>Tews</surname><given-names>G</given-names></name></person-group><article-title>Group culture of human zygotes is superior to individual culture in terms of blastulation, implantation and life birth</article-title><source>Reprod Biomed Online</source><year>2010</year><volume>21</volume><issue>6</issue><fpage>762</fpage><lpage>768</lpage><pub-id pub-id-type="pmid">21051291</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stojkovic</surname><given-names>M</given-names></name><name><surname>Kolle</surname><given-names>S</given-names></name><name><surname>Peinl</surname><given-names>S</given-names></name><name><surname>Stojkovic</surname><given-names>P</given-names></name><name><surname>Zakhartchenko</surname><given-names>V</given-names></name><name><surname>Thompson</surname><given-names>JG</given-names></name><etal></etal></person-group><article-title>Effects of high concentrations of hyaluronan in culture medium on development and survival rates of fresh and frozen-thawed bovine embryos produced in vitro</article-title><source>Reproduction</source><year>2002</year><volume>124</volume><issue>1</issue><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">12090927</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Maybach</surname><given-names>JM</given-names></name><name><surname>Hooper</surname><given-names>K</given-names></name><name><surname>Hasler</surname><given-names>JF</given-names></name><name><surname>Gardner</surname><given-names>DK</given-names></name></person-group><article-title>Cryo-survival and development of bovine blastocysts are enhanced by culture with recombinant albumin and hyaluronan</article-title><source>Mol Reprod Dev</source><year>2003</year><volume>64</volume><issue>1</issue><fpage>70</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">12420301</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bavister</surname><given-names>BD</given-names></name></person-group><article-title>Culture of preimplantation embryos: facts and artifacts</article-title><source>Hum Reprod Update</source><year>1995</year><volume>1</volume><issue>2</issue><fpage>91</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">15726768</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karamalegos</surname><given-names>C</given-names></name><name><surname>Bolton</surname><given-names>VN</given-names></name></person-group><article-title>A prospective comparison of 'in house' and commercially prepared Earleâ€™s balanced salt solution in human in-vitro fertilization</article-title><source>Hum Reprod</source><year>1999</year><volume>14</volume><issue>7</issue><fpage>1842</fpage><lpage>1846</lpage><pub-id pub-id-type="pmid">10402402</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>P</given-names></name><name><surname>Kerin</surname><given-names>JF</given-names></name><name><surname>Warnes</surname><given-names>GM</given-names></name></person-group><article-title>Improved pregnancy rate in human in vitro fertilization with the use of a medium based on the composition of human tubal fluid</article-title><source>Fertil Steril</source><year>1985</year><volume>44</volume><issue>4</issue><fpage>493</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">3902512</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conaghan</surname><given-names>J</given-names></name><name><surname>Handyside</surname><given-names>AH</given-names></name><name><surname>Winston</surname><given-names>RM</given-names></name><name><surname>Leese</surname><given-names>HJ</given-names></name></person-group><article-title>Effects of pyruvate and glucose on the development of human preimplantation embryos in vitro</article-title><source>J Reprod Fertil</source><year>1993</year><volume>99</volume><issue>1</issue><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">8283458</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>DK</given-names></name><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Calderon</surname><given-names>I</given-names></name><name><surname>Leeton</surname><given-names>J</given-names></name></person-group><article-title>Environment of the preimplantation human embryo: metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cells</article-title><source>Fertil Steril</source><year>1996</year><volume>65</volume><issue>2</issue><fpage>349</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">8566260</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>VW</given-names></name><name><surname>Wilcox</surname><given-names>AL</given-names></name><name><surname>Peterson</surname><given-names>CM</given-names></name><name><surname>Parker-Jones</surname><given-names>K</given-names></name><name><surname>Hatasaka</surname><given-names>HH</given-names></name><name><surname>Gibson</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Comparison of four media types during 3- day human IVF embryo culture</article-title><source>Reprod Biomed Online</source><year>2005</year><volume>10</volume><issue>5</issue><fpage>600</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">15949217</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artini</surname><given-names>PG</given-names></name><name><surname>Valentino</surname><given-names>V</given-names></name><name><surname>Cela</surname><given-names>V</given-names></name><name><surname>Cristello</surname><given-names>F</given-names></name><name><surname>Vite</surname><given-names>A</given-names></name><name><surname>Genazzani</surname><given-names>AR</given-names></name></person-group><article-title>A randomized control comparison study of culture media (HTF versus P1) for human in vitro fertilization</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><year>2004</year><volume>116</volume><issue>2</issue><fpage>196</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">15358464</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauri</surname><given-names>AL</given-names></name><name><surname>Petersen</surname><given-names>CG</given-names></name><name><surname>Baruffi</surname><given-names>RL</given-names></name><name><surname>Franco JG</surname><given-names>Jr</given-names></name></person-group><article-title>A prospective, randomized comparison of two commercial media for ICSI and embryo culture</article-title><source>J Assist Reprod Genet</source><year>2001</year><volume>18</volume><issue>7</issue><fpage>378</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">11499321</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staessen</surname><given-names>C</given-names></name><name><surname>Janssenswillen</surname><given-names>C</given-names></name><name><surname>De Clerck</surname><given-names>E</given-names></name><name><surname>Van Steirteghem</surname><given-names>A</given-names></name></person-group><article-title>Controlled comparison of commercial media for human in-vitro fertilization: MÃ©nÃ©zoB2 medium versus Medi-Cult universal and BM1 medium</article-title><source>Hum Reprod</source><year>1998</year><volume>13</volume><issue>9</issue><fpage>2548</fpage><lpage>2554</lpage><pub-id pub-id-type="pmid">9806281</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Langendonckt</surname><given-names>A</given-names></name><name><surname>Demylle</surname><given-names>D</given-names></name><name><surname>Wyns</surname><given-names>C</given-names></name><name><surname>Nisolle</surname><given-names>M</given-names></name><name><surname>Donnez</surname><given-names>J</given-names></name></person-group><article-title>Comparison of G1.2/G2.2 and Sydney IVF cleavage/ blastocyst sequential media for the culture of human embryos: a prospective, randomized, comparative study</article-title><source>Fertil Steril</source><year>2001</year><volume>76</volume><issue>5</issue><fpage>1023</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">11704128</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zollner</surname><given-names>KP</given-names></name><name><surname>Zollner</surname><given-names>U</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Dietl</surname><given-names>J</given-names></name><name><surname>Steck</surname><given-names>T</given-names></name></person-group><article-title>Comparison of two media for sequential culture after IVF and ICSI shows no differences in pregnancy rates: a randomized trial</article-title><source>Med Sci Monit</source><year>2004</year><volume>10</volume><issue>1</issue><fpage>CR1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14704629</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pool</surname><given-names>TB</given-names></name></person-group><article-title>Development of culture media for human assisted reproductive technology</article-title><source>Fertili Steril</source><year>2004</year><volume>81</volume><issue>2</issue><fpage>287</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">14967361</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>M</given-names></name><name><surname>Gardner</surname><given-names>DK</given-names></name></person-group><article-title>Embryo culture medium: which is the best?</article-title><source>Best Pract Res Clin Obstet Gynaecol</source><year>2007</year><volume>21</volume><issue>1</issue><fpage>83</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">17090393</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leniaud</surname><given-names>L</given-names></name><name><surname>Poncelet</surname><given-names>C</given-names></name><name><surname>Porcher</surname><given-names>R</given-names></name><name><surname>Martin-Pont</surname><given-names>B</given-names></name><name><surname>CÃ©drin- Durnerin</surname><given-names>I</given-names></name><name><surname>Hugues</surname><given-names>JN</given-names></name><etal></etal></person-group><article-title>Prospective evaluation of elective single-embryo transfer versus double-embryo transfer following in vitro fertilization: a two-year French hospital experience</article-title><source>Gynecol Obstet Fertil</source><year>2008</year><volume>36</volume><issue>2</issue><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">18255330</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>RN</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Craft</surname><given-names>IL</given-names></name><name><surname>Abdulwahid</surname><given-names>NA</given-names></name><name><surname>Jacobs</surname><given-names>HS</given-names></name></person-group><article-title>Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins</article-title><source>Lancet</source><year>1984</year><volume>2</volume><issue>8414</issue><fpage>1284</fpage><lpage>1285</lpage><pub-id pub-id-type="pmid">6150318</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Steirteghem</surname><given-names>AC</given-names></name><name><surname>Nagy</surname><given-names>ZP</given-names></name><name><surname>Joris</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Staessen</surname><given-names>C</given-names></name><name><surname>Smitz</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>High fertilization and implantation rates after intracytoplasmic sperm injection</article-title><source>Hum Reprod</source><year>1993</year><volume>8</volume><issue>7</issue><fpage>1061</fpage><lpage>1066</lpage><pub-id pub-id-type="pmid">8408487</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Rumste</surname><given-names>MM</given-names></name><name><surname>Evers</surname><given-names>JL</given-names></name><name><surname>Farquhar</surname><given-names>CM</given-names></name><name><surname>Blake</surname><given-names>DA</given-names></name></person-group><article-title>Intracytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation</article-title><source>Cochrane Database Syst Rev</source><year>2000</year><issue>2</issue><fpage>CD001301</fpage><lpage>CD001301</lpage><pub-id pub-id-type="pmid">10796764</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>P</given-names></name></person-group><article-title>The development and impact of culture media for assisted reproductive technologies</article-title><source>Fertil Steril</source><year>2004</year><volume>81</volume><issue>1</issue><fpage>27</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">14711540</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staessen</surname><given-names>C</given-names></name><name><surname>Van den Abbeel</surname><given-names>E</given-names></name><name><surname>Janssenswillen</surname><given-names>C</given-names></name><name><surname>Devroey</surname><given-names>P</given-names></name><name><surname>Van Steirteghem</surname><given-names>AC</given-names></name></person-group><article-title>Controlled comparison of Earleâ€™s balanced salt solution with MÃ©nÃ©zoB2 medium for human in-vitro fertilization performance</article-title><source>Human Reprod</source><year>1994</year><volume>9</volume><issue>10</issue><fpage>1915</fpage><lpage>1919</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><collab>Sifer Ch, Handelsman D, Grange E, Porcher R, Poncelet C, Martin-Pont B, et al</collab><article-title>An auto-controlled prospective comparison of two embryos culture media (G III series versus ISM) for IVF and ICSI treatments</article-title><source>J Assist Reprod Genet</source><year>2009</year><volume>26</volume><issue>11-12</issue><fpage>575</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">19904601</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fechtali</surname><given-names>B</given-names></name><name><surname>Moor</surname><given-names>P</given-names></name><name><surname>Roman</surname><given-names>K</given-names></name><name><surname>Tranchant</surname><given-names>S</given-names></name><name><surname>Porcher</surname><given-names>R</given-names></name><name><surname>Rudant</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Comparison of two embryos culture media in IVF and ICSI therapy</article-title><source>Hum Reprod</source><year>2004</year><volume>19</volume><issue>Suppl 1</issue><fpage>i147</fpage><lpage>148</lpage></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xella</surname><given-names>S</given-names></name><name><surname>Marsella</surname><given-names>T</given-names></name><name><surname>Tagliasacchi</surname><given-names>D</given-names></name><name><surname>Giulini</surname><given-names>S</given-names></name><name><surname>La Marca</surname><given-names>A</given-names></name><name><surname>Tirelli</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium</article-title><source>Fertil Steril</source><year>2010</year><volume>93</volume><issue>6</issue><fpage>1850</fpage><lpage>1863</lpage><pub-id pub-id-type="pmid">19152877</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houghton</surname><given-names>FD</given-names></name><name><surname>Leese</surname><given-names>HJ</given-names></name></person-group><article-title>Metabolism and developmental competence of the preimplantation embryo</article-title><source>Eur J Obstet Gynecol Reprod Biol</source><year>2004</year><volume>115</volume><issue>1</issue><fpage>S92</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15196724</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><collab>Menezo Y Jr, Russo G, Tosti E, El Mouatassim S, Benkhalifa M</collab><article-title>Expression profile of genes coding for DNA repair in human oocytes using pangenomic microarrays, with a special focus on ROS linked decays</article-title><source>J Assist Reprod Genet</source><year>2007</year><volume>24</volume><issue>11</issue><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">17899356</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>DH</given-names></name><name><surname>Madan</surname><given-names>P</given-names></name></person-group><article-title>Permanent embryo arrest: molecular and cellular concepts</article-title><source>Mol Hum Reprod</source><year>2008</year><volume>14</volume><issue>8</issue><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">18511487</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favetta</surname><given-names>LA</given-names></name><name><surname>Madan</surname><given-names>P</given-names></name><name><surname>Mastromonaco</surname><given-names>GF</given-names></name><name><surname>St John</surname><given-names>EJ</given-names></name><name><surname>King</surname><given-names>WA</given-names></name><name><surname>Betts</surname><given-names>DH</given-names></name></person-group><article-title>The oxidative stress adaptor p66Shc is required for permanent embryo arrest in vitro</article-title><source>BMC Dev Biol</source><year>2007</year><volume>7</volume><fpage>132</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">18047664</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helmerhorst</surname><given-names>FM</given-names></name><name><surname>Perquin</surname><given-names>DA</given-names></name><name><surname>Donker</surname><given-names>D</given-names></name><name><surname>Keirse</surname><given-names>MJ</given-names></name></person-group><article-title>Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies</article-title><source>BMJ</source><year>2004</year><volume>328</volume><issue>7434</issue><fpage>261</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">14742347</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>RA</given-names></name><name><surname>Gibson</surname><given-names>KA</given-names></name><name><surname>Wu</surname><given-names>YW</given-names></name><name><surname>Croughan</surname><given-names>MS</given-names></name></person-group><article-title>Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis</article-title><source>Obstet Gynecol</source><year>2004</year><volume>103</volume><issue>3</issue><fpage>551</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">14990421</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutcliffe</surname><given-names>AG</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name></person-group><article-title>Outcome of assisted reproduction</article-title><source>Lancet</source><year>2007</year><volume>370</volume><issue>9584</issue><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">17662884</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Rogers</surname><given-names>JM</given-names></name></person-group><article-title>Embryonic and fetal programming of physiological disorders in adulthood</article-title><source>Birth Defects Res C Embryo Today</source><year>2004</year><volume>72</volume><issue>4</issue><fpage>300</fpage><lpage>312</lpage><pub-id pub-id-type="pmid"></pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horsthemke</surname><given-names>B</given-names></name><name><surname>Ludwig</surname><given-names>M</given-names></name></person-group><article-title>Assisted reproduction: the epigenetic perspective</article-title><source>Hum Reprod Update</source><year>2005</year><volume>11</volume><issue>5</issue><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">15994847</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>F</given-names></name><name><surname>Shanbhag</surname><given-names>S</given-names></name><name><surname>Templeton</surname><given-names>A</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name></person-group><article-title>Obstetric outcome in women with subfertility</article-title><source>BJOG</source><year>2005</year><volume>112</volume><issue>5</issue><fpage>632</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">15842289</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>FernaÂ´ndez-Gonzalez</surname><given-names>R</given-names></name><name><surname>Ramirez</surname><given-names>MA</given-names></name><name><surname>Bilbao</surname><given-names>A</given-names></name><name><surname>De Fonseca</surname><given-names>FR</given-names></name><name><surname>GutieÂ´rrez- AdaÂ´n</surname><given-names>A</given-names></name></person-group><article-title>Suboptimal in vitro culture conditions: an epigenetic origin of long-term health effects</article-title><source>Mol Reprod Dev</source><year>2007</year><volume>74</volume><issue>9</issue><fpage>1149</fpage><lpage>1156</lpage><pub-id pub-id-type="pmid">17474101</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>DK</given-names></name><name><surname>Reed</surname><given-names>L</given-names></name><name><surname>Linck</surname><given-names>D</given-names></name><name><surname>Sheehan</surname><given-names>C</given-names></name><name><surname>Lane</surname><given-names>M</given-names></name></person-group><article-title>Quality control in human in vitro fertilization</article-title><source>Semin Reprod Med</source><year>2005</year><volume>23</volume><issue>4</issue><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">16317620</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Geyter</surname><given-names>C</given-names></name><name><surname>De Geyter</surname><given-names>M</given-names></name><name><surname>Steimann</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Holzgreve</surname><given-names>W</given-names></name></person-group><article-title>Comparative birth weights of singletons born after assisted reproduction and natural conception in previously infertile women</article-title><source>Hum Reprod</source><year>2006</year><volume>21</volume><issue>3</issue><fpage>705</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">16284064</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>DP</given-names></name></person-group><article-title>Competition a common motif for the imprinting mechanism?</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><issue>23</issue><fpage>6899</fpage><lpage>6905</lpage><pub-id pub-id-type="pmid">9384569</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maher</surname><given-names>ER</given-names></name></person-group><article-title>Imprinting and assisted reproductive technology</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><issue>suppl 1</issue><fpage>R133</fpage><lpage>R138</lpage><pub-id pub-id-type="pmid">15809265</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>W</given-names></name><name><surname>Moore</surname><given-names>T</given-names></name></person-group><article-title>Polyandry, life-history trade-offs and the evolution of imprinting at Mendelian loci</article-title><source>Genetics</source><year>2004</year><volume>168</volume><issue>4</issue><fpage>2317</fpage><lpage>2327</lpage><pub-id pub-id-type="pmid">15611195</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassuto</surname><given-names>G</given-names></name><name><surname>Chavrier</surname><given-names>M</given-names></name><name><surname>Menezo</surname><given-names>Y</given-names></name></person-group><article-title>Culture conditions and not prolonged culture time are responsible for monozygotic twinning in human in vitro fertilization</article-title><source>Fertil Steril</source><year>2003</year><volume>80</volume><issue>2</issue><fpage>462</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">12909518</pub-id></element-citation></ref></ref-list></back></article>